AstraZeneca (AZN)
(Delayed Data from NSDQ)
$77.34 USD
+0.54 (0.70%)
Updated Jul 5, 2024 04:00 PM ET
After-Market: $77.33 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Price, Consensus and EPS Surprise
AZN 77.34 +0.54(0.70%)
Will AZN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AZN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AZN
AstraZeneca's (AZN) Tagrisso Gets EU Nod for First-Line NSCLC
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
AZN: What are Zacks experts saying now?
Zacks Private Portfolio Services
AstraZeneca (AZN) Imfinzi Combo Gets CHMP Nod for Expanded Use
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
Other News for AZN
TOP NEWS: AstraZeneca drug Tagrisso gets EU approval for cancer form
AIM WINNERS & LOSERS: Aptamer rises on AstraZeneca contract
Aptamer shares jump as inks agreement with AstraZeneca
GLOBAL BROKER RATINGS: Redburn raises Siemens Energy to 'buy'
LONDON BROKER RATINGS: Deutsche Bank cuts Quilter, ups Polar Capital